{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:47:48Z","timestamp":1792853268226,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jtct.2022.11.018","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:02:43Z","timestamp":1669377763000},"page":"111.e1-111.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Feasibility of a Hospital-at-Home Program for Autologous Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Soledad","family":"Gonz\u00e1lez-Barrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Mart\u00edn-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4234-4832","authenticated-orcid":false,"given":"Juan Jos\u00e9","family":"Parra-Jord\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fern\u00e1ndez-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Lobeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrecia","family":"Ya\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Baro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arancha","family":"Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5765-0085","authenticated-orcid":false,"given":"Enrique M.","family":"Ocio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Sanroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.11.018_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","article-title":"Haematopoietic stem cell transplants: principles and indications","volume":"80","author":"Balassa","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.jtct.2022.11.018_bib0003","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.1995.13.6.1323","article-title":"Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial","volume":"13","author":"Klumpp","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0004","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.1994.12.5.1005","article-title":"Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support","volume":"12","author":"Gilbert","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0005","article-title":"Multiple myeloma outpatient transplant program in the era of novel agents: state-of-the-art","volume":"10:592487","author":"Martino","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/M19-0600","article-title":"Hospital-level care at home for acutely ill adults a randomized controlled trial","volume":"172","author":"Levine","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2022.11.018_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cger.2008.10.002","article-title":"Hospital at home","volume":"25","author":"Cheng","year":"2009","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jtct.2022.11.018_bib0008","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.medcli.2011.04.008","article-title":"[Hospital at home: an opportunity for change]","volume":"138","author":"Cuxart M\u00e8lich","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jtct.2022.11.018_bib0009","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/j.1532-5415.2004.52579_1.x","article-title":"Home hospital - toward a tighter definition","volume":"52","author":"Leff","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jtct.2022.11.018_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1503\/cmaj.081891","article-title":"Defining and disseminating the hospital-at-home model","volume":"180","author":"Leff","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jtct.2022.11.018_bib0011","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clml.2015.05.006","article-title":"Outpatient autologous stem cell transplantation for patients with myeloma","volume":"15","author":"Paul","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2022.11.018_bib0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/10428194.2014.931952","article-title":"A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study","volume":"56","author":"Martino","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.11.018_bib0013","unstructured":"World Health Organization. WHO handbook for reporting results of cancer treatment. 1979. WHO offset publication No. 48. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37200\/WHO_OFFSET_48.pdf. Accessed: October 2022"},{"key":"10.1016\/j.jtct.2022.11.018_bib0014","series-title":"Tratamiento Antimicrobiano Domiciliario Endovenoso","author":"Mir\u00f3n","year":"2008"},{"key":"10.1016\/j.jtct.2022.11.018_bib0015","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4065\/83.10.1131","article-title":"Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative","volume":"83","author":"Gertz","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jtct.2022.11.018_bib0016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbmt.2012.12.006","article-title":"Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1537-2995.2007.01073.x","article-title":"Outpatient high-dose melphalan in multiple myeloma patients","volume":"47","author":"Kassar","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2022.11.018_bib0018","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.clml.2019.09.619","article-title":"Outpatient autologous stem cell transplants for multiple myeloma: analysis of safety and outcomes in a tertiary care center","volume":"19","author":"Kodad","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2022.11.018_bib0019","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbmt.2014.03.027","article-title":"Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study","volume":"20","author":"Martino","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/10428190802535098","article-title":"Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease","volume":"50","author":"Anastasia","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.11.018_bib0021","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1200\/JCO.2006.06.4238","article-title":"Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies","volume":"24","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0022","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/bmt.2015.287","article-title":"At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study","volume":"51","author":"Mart\u00ednez-Cibrian","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0023","unstructured":"Martinez-Roca A, Rodriguez-Lobato LG, Ballester N. Trasplante personalizado de c\u00e9lulas madre hematopoy\u00e9ticas aut\u00f3logas en el hogar durante el. Brote de SARS-CoV-2. Leuk Res. 2021:106."},{"key":"10.1016\/j.jtct.2022.11.018_bib0024","first-page":"649","article-title":"Toxicology and response criteria of the Eastern Cooperative Oncology Group","author":"Oken","year":"19825","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/bmt.2017.77","article-title":"Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore","volume":"52","author":"Abid","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0026","first-page":"1192","article-title":"Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma","volume":"87","author":"Morabito","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.11.018_bib0027","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.thj.6200349","article-title":"Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma","volume":"5","author":"Ferrara","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.jtct.2022.11.018_bib0028","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1080\/10428194.2021.1876870","article-title":"Results of a completely outpatient autologous stem cell transplant program for lymphoma patients receiving reduced-intensity conditioning","volume":"62","author":"Jaime-P\u00e9rez","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.11.018_bib0029","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/10428194.2020.1742901","article-title":"Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients","volume":"61","author":"Rodr\u00edguez-Lobato","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.11.018_bib0031","first-page":"364","article-title":"Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue","volume":"4","author":"Meisenberg","year":"1996","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2022.11.018_bib0032","first-page":"1808","article-title":"Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation","author":"Satlin MJ","year":"201521","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241778","article-title":"The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever","volume":"15","author":"Rodr\u00edguez-Lobato","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.11.018_bib0034","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/1078155219865303","article-title":"Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin","volume":"26","author":"Petteys","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jtct.2022.11.018_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.idc.2019.02.003","article-title":"Work-up for fever during neutropenia for both the stem cell transplant recipient and the hematologic malignancy patient","volume":"33","author":"Satyanarayana","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jtct.2022.11.018_bib0036","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41409-020-0811-y","article-title":"Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey","volume":"55","author":"Verlinden","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0037","article-title":"Hospital in the home (HITH) care following autologous stem cell transplantation for lymphoma and multiple myeloma","volume":"23:34-39","author":"Johnson","year":"2006","journal-title":"Aust J Adv Nurs"},{"key":"10.1016\/j.jtct.2022.11.018_bib0038","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","article-title":"Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care","volume":"100","author":"Svahn","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.11.018_bib0039","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/trf.14816","article-title":"Home transfusion: three decades of practice at a tertiary care hospital","volume":"58","author":"Garc\u00eda","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2022.11.018_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1026427724108","article-title":"At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies","volume":"10","author":"Westermann","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0041","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41409-019-0768-x","article-title":"A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe","volume":"55","author":"Guti\u00e9rrez-Garc\u00eda","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0042","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bmt.1701747","article-title":"Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies","volume":"23","author":"Iestra","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.11.018_bib0043","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00277-013-1872-4","article-title":"Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients","volume":"93","author":"Pi\u00f1ana","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2022.11.018_bib0044","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S1478951520000954","article-title":"Exploring the caregiver's experience in an innovative homebound hematopoietic stem cell transplantation program","volume":"19","author":"Jenkelowitz","year":"2021","journal-title":"Palliat Support Care"},{"issue":"4","key":"10.1016\/j.jtct.2022.11.018_bib45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/bmt.2011.126","article-title":"Randomized study of early hospital discharge following autologous blood SCT: Medical outcomes and hospital costs","volume":"47","author":"Faucher","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2022.11.018_bib0046","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bmt.1702044","article-title":"Cannell PK Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma","volume":"24","author":"Herrmann","year":"1999","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:09:17Z","timestamp":1763003357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722017869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2666636722017869"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.11.018","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of a Hospital-at-Home Program for Autologous Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}